Latest Breaking News On - Pulmonary inflammation mediates durable - Page 1 : comparemela.com

Arrowhead Pharmaceuticals, Inc : Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023

Arrowhead Pharmaceuticals, Inc : Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergJason bracoBrian ritchieVince anzaloneSubcutaneous administration mediates pulmonaryArrowhead pharmaceuticals incEuropean respiratory societyInternational congressExchange commissionLifesci advisorsEuropean respiratory society international congressLifesci communicationsArrowhead pharmaceuticalsArrowhead expandsAddress diseasesBreaking clinical data

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jason bracoVince anzaloneBrian ritchieEuropean respiratory society international congressSubcutaneous administration mediates pulmonaryArrowhead pharmaceuticalsEuropean respiratory societyLifesci communicationsArrowhead pharmaceuticals incLifesci advisorsExchange commissionInternational congressAddress diseasesBreaking clinical dataAsthma demonstrate deepDurable gene silencing

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR)

- Arrowhead Expands the Reach of RNAi Therapies to Address Diseases in the Lung - Late-Breaking Clinical Data for ARO-RAGE for Treatment of Asthma Demonstrate Deep and Durable Gene Silencing - Promising Preclinical

International congressArrowhead pharmaceuticalsSubcutaneous administration mediates pulmonaryEuropean respiratory societyArrowhead pharmaceuticals incEuropean respiratory society international congressAddress diseasesBreaking clinical dataAsthma demonstrate deepDurable gene silencingEuropean respiratory society internationalJavier san martinPulmonary inflammation mediates durableNonhuman primatesTherapeutics delivery platform compatibleFirst in human study

Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences

Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events: Citi’s 18th Annual BioPharma Conference – September 6, 2023 Type: 1-on-1.

Arrowhead pharmaceuticalsSubcutaneous administration mediates pulmonaryExchange commissionArrowhead pharmaceuticals incMorgan stanleyEuropean respiratory societyInternational congressAnnual biopharma conferenceRespiratory societyPoster sessionClinical stage inhaledPulmonary inflammation mediates durableNonhuman primatesTherapeutics delivery platform compatibleLate breaking abstractFirst in human study